- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/38 - Nitrogen atoms
Patent holdings for IPC class C07D 277/38
Total number of patents in this class: 100
10-year publication summary
|
5
|
7
|
5
|
4
|
2
|
5
|
5
|
1
|
6
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer AG | 3364 |
9 |
| Modernatx, Inc. | 1296 |
9 |
| Duke University | 3091 |
5 |
| Chaperone Therapeutics, Inc | 5 |
4 |
| Ganymede Oncology, Inc. | 6 |
3 |
| Bristol-myers Squibb Company | 4850 |
2 |
| F. Hoffmann-La Roche AG | 7947 |
2 |
| The Regents of the University of California | 20137 |
2 |
| Deutsches Krebsforschungszentrum | 418 |
2 |
| DONGWOO FINE-CHEM Co., Ltd. | 1364 |
2 |
| Romark Laboratories L.C. | 52 |
2 |
| Impetis Biosciences Ltd. | 29 |
2 |
| Wigen Biomedicine Technology (Shanghai) Co., Ltd. | 123 |
2 |
| Eddingpharm (Hong Kong) Company Limited | 8 |
2 |
| Hoffmann-La Roche Inc. | 3484 |
1 |
| AstraZeneca AB | 2877 |
1 |
| Boehringer Ingelheim International GmbH | 4648 |
1 |
| Bayer Cropscience AG | 2009 |
1 |
| The Regents of the University of Michigan | 4753 |
1 |
| The Trustees of Columbia University in the City of New York | 3592 |
1 |
| Other owners | 46 |